-
Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead
Friday, November 8, 2024 - 9:59am | 712Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results on Friday for the second quarter of fiscal 2025, which ended Sept. 30, 2024. The Canadian cannabis giant reported a 9% year-over-year decrease in net revenue to CA$63 million ($45.4 million). Canopy said excluding net...
-
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
Thursday, September 5, 2024 - 9:22am | 507Irish psychedelic biotech firm GH Research PLC (NASDAQ:GHRS) reported its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash,...
-
Entourage Cannabis Co.'s Q2 Revenue Drops Nearly 9% YoY, CEO 'Optimistic' About Future Opportunities
Tuesday, August 27, 2024 - 9:37am | 442Canadian cannabis producer and distributor Entourage Health Corp. (TSXV:ENTG) (OTCQX:ETRGF) (FSE:4WE) announced its second quarter financial results on Tuesday for the three-month period ending June 30, 2024. The Toronto-based company reported a total revenue of CA$12.2 million ($9 million),...
-
Vext Cannabis Co.'s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver
Tuesday, August 20, 2024 - 9:27am | 537In its second-quarter financial results for the period ended June 30, 2024, Vext Science, Inc. (CSE:VEXT) (OTCQX:VEXTF) reported a year-over-year drop in revenue from $9.2 million in the second quarter of fiscal 2023, to $8.4 million in this year's corresponding period. As a company with vertical...
-
Blüm Cannabis Co. Reports 111% Increase In Q2 Revenue Following 'Transformative' Sale Of Santa Ana Dispensary
Thursday, August 15, 2024 - 12:48pm | 404California cannabis company Blüm Holdings, Inc. (OTCQB:BLMH) announced its second-quarter financial results on Thursday for the three months ended June 30, 2024. Patty Chan, the company's CFO called Blüm's financial results and sale of Blüm Santa Ana "financial milestones" and "the culmination of...
-
Auxly Cannabis Co Sets Q2 Record In Revenue Following 33% YoY Increase, Reports Best Quarter In History
Thursday, August 15, 2024 - 10:47am | 441Cannabis consumer packaged goods company Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB:CBWTF) announced on Thursday its second quarter financial results for the three months ended June 30, 2024, revealing net revenues of CA$29.2 million ($21.3 million). That's an increase of 33% year-over-year and 16...
-
Cannabis-Focused Software Co. SpringBig Narrows Q2 Net Loss, Reports 8.3% YoY Drop In Revenue
Wednesday, August 14, 2024 - 1:57pm | 397SpringBig Holdings, Inc. (OTCQX:SBIG), a provider of SaaS-based marketing solutions, consumer mobile app experiences and omni-channel loyalty programs, announced its financial results Tuesdayfor the second quarter ended June 30, 2024. Revenue for the period totaled $6.6 million, down from $7.2...
-
Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches
Wednesday, August 14, 2024 - 10:33am | 568Decibel Cannabis Company Inc. (TSXV:DB) (OTCQB:DBCCF) reported on Wednesday its unaudited interim financial results for the second quarter ending June 30, 2024. “Decibel has shown good discipline in reducing our current liabilities by ~5mm this quarter," said Benjamin Sze, Decibel’s...
-
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
Wednesday, August 14, 2024 - 9:43am | 735IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million ($10.8 million) in the second quarter of 2023. The...
-
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Wednesday, August 14, 2024 - 8:50am | 485Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). “We are...
-
Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2
Tuesday, August 13, 2024 - 11:25am | 376CV Sciences, Inc. (OTCQB:CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year at $4 million for the period. "Revenues for our core business remained stable at $4 million in the...
-
Canadian Cannabis Operations Drive Growth For Village Farms In Q2, Plans To Cash In On Marijuana Program In The Netherlands
Thursday, August 8, 2024 - 12:19pm | 533Village Farms International, Inc. (NASDAQ:VFF) today reported its financial results for the second quarter that ended June 30, 2024, revealing that total sales grew 19% year-over-year to $92.1 million for the period. The Vancouver-based company said Canadian cannabis grew net sales by 45% and...
-
Cannabis Co. Cresco Lab's Q2 Gross Profit Increases Over 9% YoY, Reports Nearly 7% Drop In Revenue
Thursday, August 8, 2024 - 11:56am | 448Cannabis producer and operator of Sunnyside dispensaries, Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) released its financial and operating results Thursday for the second quarter ended June 30, 2024. "Our Q2 results demonstrate the sustainability of the improvements we've made to the...
-
Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue
Thursday, August 8, 2024 - 8:51am | 421Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) announced on Tuesday its 2024 second-quarter business results. The company reported $27.8 million in net revenue during the quarter, representing a 46% year-over-year increase. Mike Gorenstein, chairman, president and CEO of Cronos, said that's the "...
-
Trulieve Touts Third Consecutive Quarter Of Revenue Growth, Narrows Q2 Net Loss 97% YoY, Launches Cannabis Sales In Ohio
Tuesday, August 6, 2024 - 9:11am | 799Trulieve Cannabis Corp. announced on Tuesday its second-quarter results for the three months ended June 30, 2024. The Florida medical cannabis giant reported a 2% quarter-over-quarter and 8% year-over-year increase to $303 million, with 95% of the sum coming from retail sales, driven by higher...